4021
Nissan Chemical Corporation
日産化学株式会社
Basic Materials · Chemicals
Nissan Chemical Corporation engages in the chemicals, performance materials, agricultural chemicals, and pharmaceuticals businesses in Japan and internationally. The company provides high purity and custom chemicals; AdBlue, an urea solution; ammonia, sulfuric, and nitric acid, as well as concrete products; TEPIC, an epoxy compound; Melamine Cyanurate, a salt of melamine and iso cyanuric acid; TEPIC-VL, a liquid epoxy compound; Nissan Reishi, a health food; phenylphosphonic acid; HI-LITE, a chlorinated isocyanulate; FINEOXOCOL, a saturated fatty alcohol and acid; HARDBEADS, a spherical fine particles; STARFINE, a Triazine based adhesion; melamine polyphosphate; and NFG, a highly functional additive. It also offers performance materials comprising display, semiconductor, and inorganic materials; agricultural chemicals, such as herbicides, insecticides, fungicides, etc. for use on agricultural land, as well as in golf courses and parks; and drug substances for antiparasite drugs for animals. In addition, the company provides pharmaceutical products, such as LIVALO, a antihypercholesterolemic agent; LANDEL and FINTE, a long-acting calcium channel blocker; and APIs and intermediaries, as well as develops NTC-801, a pharmacological therapeutic agent for treatment of arrhythmia. Further, it develops healthcare, information and communication, and energy materials. The company was formerly known as Nissan Chemical Industries, Ltd. and changed its name to Nissan Chemical Corporation in July 2018. Nissan Chemical Corporation was founded in 1887 and is headquartered in Tokyo, Japan.
Price
¥7,509
Market Cap
¥1.0T
Ent. Value
¥1.0T
Net Debt
−¥4.0B
Shares Out.
136.4M
P / E
24.0×
EV / EBIT
18.1×
P / Book
4.39×
P / NCAV
8.85×
Div. Yield
2.32%
Financials
| Metric |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|
| Net Sales | ¥251.4B | ¥226.7B | ¥228.1B | ¥208.0B |
| Cost of Sales | ¥134.8B | ¥121.9B | ¥121.3B | ¥106.9B |
| Gross Profit | ¥116.5B | ¥104.8B | ¥106.8B | ¥101.1B |
| SG&A | ¥59.7B | ¥56.6B | ¥54.5B | ¥50.1B |
| Operating Income | ¥56.8B | ¥48.2B | ¥52.3B | ¥51.0B |
| Non-Operating Income | ¥4.3B | ¥5.3B | ¥5.0B | ¥3.8B |
| Dividend Income | ¥1.7B | ¥1.6B | ¥1.3B | ¥768M |
| Interest Income | ¥217M | ¥161M | ¥203M | ¥49M |
| Non-Operating Expenses | ¥3.1B | ¥1.9B | ¥1.5B | ¥1.1B |
| Interest Expense | ¥654M | ¥526M | ¥252M | ¥73M |
| Ordinary Income | ¥58.0B | ¥51.6B | ¥55.8B | ¥53.7B |
| Pre-tax Income | ¥59.5B | ¥51.8B | ¥56.6B | ¥54.2B |
| Income Taxes | ¥16.5B | ¥13.6B | ¥15.2B | ¥15.0B |
| Current Tax | ¥17.3B | ¥12.8B | ¥14.6B | ¥14.7B |
| Deferred Tax | ¥-828M | ¥730M | ¥633M | ¥312M |
| Net Income (owners) | ¥43.0B | ¥38.0B | ¥41.1B | ¥38.8B |
| Minority Interest | ¥-92M | ¥172M | ¥329M | ¥357M |
| Comprehensive Income | ¥39.4B | ¥42.5B | ¥41.7B | ¥36.5B |
| EBITDA | ¥71.2B | ¥62.0B | ¥63.3B | ¥61.2B |
| Goodwill Amort. (J-GAAP) | ¥53M | ¥101M | ¥101M | ¥103M |
| EPS | ¥313.26 | ¥272.82 | ¥291.36 | ¥271.88 |
| Shares Outstanding | 136.4M | 138.8M | 140.4M | 141.8M |
| Shares Issued (total) | 136.8M | 138.8M | 141.3M | 143.0M |
| Treasury Shares | 0.4M | 0.0M | 0.9M | 1.2M |
| Metric |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | ¥330.8B | ¥323.5B | ¥298.7B | ¥279.7B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Current Assets | ¥210.4B | ¥202.0B | ¥189.5B | ¥175.3B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Cash & Deposits | ¥27.5B | ¥22.7B | ¥29.6B | ¥34.7B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Trade Receivables | ¥89.1B | ¥88.8B | ¥82.7B | ¥80.0B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-Current Assets | ¥120.4B | ¥121.5B | ¥109.3B | ¥104.4B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| PP&E | ¥72.4B | ¥77.4B | ¥64.7B | ¥53.2B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Intangible Assets | ¥13.5B | ¥10.7B | ¥11.5B | ¥11.8B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investment Securities | ¥24.4B | ¥26.1B | ¥27.3B | ¥30.2B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Tax Assets | ¥567M | ¥519M | ¥531M | ¥918M | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Liabilities | ¥94.6B | ¥92.6B | ¥77.2B | ¥71.7B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Current Liabilities | ¥79.2B | ¥86.6B | ¥72.2B | ¥66.0B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Accounts Payable | ¥19.9B | ¥20.4B | ¥19.9B | ¥19.0B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ST Debt | ¥20.5B | ¥39.7B | ¥26.0B | ¥21.5B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Taxes Payable | ¥10.0B | ¥4.9B | ¥7.9B | ¥8.7B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Non-Current Liabilities | ¥15.4B | ¥6.0B | ¥5.0B | ¥5.7B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total LT Borrowings | ¥11.0B | ¥1.3B | ¥1.3B | ¥1.2B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Pension Obligations | ¥542M | ¥467M | ¥377M | ¥290M | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deferred Tax Liab. | ¥1.1B | ¥1.4B | ¥98M | ¥69M | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Equity | ¥236.2B | ¥230.9B | ¥221.5B | ¥208.0B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Capital Stock | ¥18.9B | ¥18.9B | ¥18.9B | ¥18.9B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Capital Surplus | ¥13.6B | ¥13.6B | ¥13.6B | ¥13.6B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Retained Earnings | ¥192.9B | ¥182.3B | ¥182.4B | ¥172.4B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Treasury Stock | ¥-2.6B | ¥-943M | ¥-6.1B | ¥-8.3B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AOCI | ¥10.4B | ¥13.5B | ¥9.6B | ¥9.2B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity (owners) | ¥222.9B | ¥213.9B | ¥208.8B | ¥196.7B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Minority Interests | ¥2.9B | ¥3.4B | ¥3.1B | ¥2.1B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Total Interest-Bearing Debt ⓘ | ¥31.5B | ¥41.0B | ¥27.3B | ¥22.7B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Cash ⓘ | ¥-4.0B | ¥-18.2B | ¥2.4B | ¥11.9B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NCAV ⓘ | ¥115.8B | ¥109.4B | ¥112.3B | ¥103.6B | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NCAV/Share | ¥849 | ¥789 | ¥799 | ¥731 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BV/Share | ¥1,634 | ¥1,542 | ¥1,487 | ¥1,387 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Metric |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|
| Operating CF | ¥59.2B | ¥33.7B | ¥35.2B | ¥41.9B |
| Interest Paid | ¥-635M | ¥-525M | ¥-251M | ¥-73M |
| Interest Received | ¥3.2B | ¥2.2B | ¥2.2B | ¥1.9B |
| D&A | ¥14.3B | ¥13.7B | ¥10.9B | ¥10.1B |
| Goodwill Amort. | ¥53M | ¥101M | ¥101M | ¥103M |
| Investing CF | ¥-17.6B | ¥-18.7B | ¥-19.6B | ¥-12.4B |
| CapEx | ¥15.4B | ¥18.6B | ¥18.2B | ¥11.3B |
| Purchase Investments | ¥-216M | ¥-125M | ¥-506M | ¥-190M |
| Proceeds from Invest. | ¥1M | ¥1.7B | ¥2.5B | ¥4.2B |
| Financing CF | ¥-35.6B | ¥-22.1B | ¥-25.0B | ¥-27.9B |
| Dividends Paid | ¥-22.7B | ¥-23.0B | ¥-20.1B | ¥-15.5B |
| Share Buybacks | ¥-11.5B | ¥-10.0B | ¥-9.0B | ¥-12.0B |
| LT Debt Repaid | ¥-652M | ¥-624M | ¥-552M | ¥-552M |
| Free Cash Flow | ¥43.8B | ¥15.1B | ¥17.0B | ¥30.7B |
| Net Change in Cash | ¥4.7B | ¥-6.9B | ¥-8.1B | ¥2.3B |
| Metric |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|
| ROE | 18.7% | 17.1% | 19.4% | 19.2% |
| ROA | 13.2% | 12.2% | 14.2% | 13.9% |
| EPS | ¥313.26 | ¥272.82 | ¥291.36 | ¥271.88 |
| DPS | ¥174.00 | ¥164.00 | ¥164.00 | ¥122.00 |
| BPS | ¥1,711.83 | ¥1,641.05 | ¥1,557.12 | ¥1,454.01 |
| FCF/Share | ¥321 | ¥109 | ¥121 | ¥217 |
| NCAV/Share | ¥849 | ¥789 | ¥799 | ¥731 |
| Payout Ratio | 55.5% | 60.1% | 56.3% | 44.9% |
Event Timeline
S Shareholder
A Capital Signal
Large Shareholder Reports 28
Capital Allocation Signals 2
| Date | Type | Amount | Summary | |
|---|---|---|---|---|
|
2026-05-15
15:30
|
Buyback | ¥10.5B | Board resolved to repurchase up to ¥10.5B, by 2027-03-31. | |
|
Summary
Board resolved to repurchase up to ¥10.5B, by 2027-03-31.
Deadline: 2027-03-31
Source (JP)
る割合 1.56%)
(3) 株式の取得価額の総額 10,500,000,000 円(上限とする)
(4) 株式の取得期間 2026年5月18日から2027年3月31日まで
(ご参考)2026年5月15日時点の自己株式の保有状況
発行済株式総数(自己株式を除く
自己株式取得に係る事項の決定に関するお知らせ
TDnet PDF
|
||||
|
2026-05-15
15:30
|
Div Increase | ¥17.7B ¥132.0/sh +27% | Nissan Chemical Industries announced a dividend increase for fiscal year ending March 31, 2026, with per-share dividend … | |
|
Summary
Nissan Chemical Industries announced a dividend increase for fiscal year ending March 31, 2026, with per-share dividend raised to 132 yen from 110 yen forecast (prior year: 104 yen). Total dividend payout of 17.7 billion yen approved by board for shareholder vote at June 25, 2026 AGM, reflecting strong business performance and commitment to shareholder returns.
Deadline: 2026-06-26
YoY: +27%
Source (JP)
2026年3月期の期末配当金を1株当たり110円から132円に修正いたします。配当金総額17,719百万円
剰余金の配当に関するお知らせ
TDnet PDF
|
||||
| # | Shareholder | Shares (thou.) | % of Total |
|---|---|---|---|
| 1 |
Japan Master Trust Bank
日本マスタートラスト信託銀行株式会社(信託口)
|
33,264 | 24.38% |
| 2 |
Japan Custody Bank
株式会社日本カストディ銀行(信託口)
|
15,917 | 11.67% |
| 3 |
Custody Bank of Japan, Ltd. (Trust Account)
みずほ信託銀行株式会社 退職給付信託 みずほ銀行口 再信託受託者 株式会社日本カストディ銀行
|
5,467 | 4.01% |
| 4 | JPモルガン証券株式会社 | 4,052 | 2.97% |
| 5 |
Business Partner Stock Ownership Plan
日産化学 取引先持株会
|
3,635 | 2.66% |
| 6 |
Meiji Yasuda Life Insurance
明治安田生命保険相互会社
|
1,861 | 1.36% |
| 7 |
JP MORGAN CHASE BANK
JP MORGAN CHASE BANK 385781(常任代理人 株式会社みずほ銀行決済営業部)
|
1,797 | 1.32% |
| 8 |
State Street Bank and Trust Company
STATE STREET BANK AND TRUST COMPANY 505001(常任代理人 株式会社みずほ銀行決済営業部)
|
1,700 | 1.25% |
| 9 | HSBC HONG KONG-TREASURY SERVICES A/C ASIAN EQUITIES DERIVATIVES(常任代理人 香港上海銀行東京支店カストディ業務部) | 1,663 | 1.22% |
| 10 |
STATE STREET BANK WEST CLIENT - TREATY
STATE STREET BANK WEST CLIENT - TREATY 505234(常任代理人 株式会社みずほ銀行決済営業部)
|
1,561 | 1.14% |
as of 2025-03-31
Source: EDINET ↗
Ownership by year — hover bars for detail
Domestic Nominees
40.1%
+1.9% vs 2024
Trust bank custodians — GPIF, pensions, investment trusts
Foreign Custodians
3.7%
-2.3% vs 2024
Sub-custodians for foreign asset managers
Direct / Strategic
8.2%
+1.5% vs 2024
Named entities with disclosed investment intent
Bar = % of shares outstanding · top-10 covers 52.0% · grey = other shareholders · 2025
| Shareholder | Trend | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Japan Master Trust Bank 日本マスタートラスト信託銀行 | 25.33% | 23.68% | 24.38% +0.70% | |
| Japan Custody Bank 日本カストディ銀行 | 14.79% | 14.46% | 15.68% +1.22% | |
| JPモルガン証券 NEW ENTRY | — | — | — | 2.97% NEW |
| Business Partner Stock Ownership Plan 日産化学 取引先持株会 | 2.61% | 2.71% | 2.66% -0.05% | |
| State Street | 1.57% | 4.69% | 2.39% -2.30% | |
| Meiji Yasuda Life Insurance 明治安田生命保険 | 1.33% | 1.34% | 1.36% +0.02% | |
| JP Morgan | 1.25% | 1.30% | 1.32% +0.02% | |
| HSBC HONG KONG-TREASURY SERVICES A/C ASIAN EQUITIES DERIVATIVES NEW ENTRY | — | — | — | 1.22% NEW |
| HSBC HONG KONG-TREASURYSERVICES A/C ASIAN EQUITIES DERIVATIVES last seen 2024 | Exited Top 10 | — | 1.53% | — |
| Sompo Japan Insurance Inc. 損害保険ジャパン last seen 2024 | Exited Top 10 | 1.10% | 1.11% | — |
| 農林中央金庫 last seen 2023 | Exited Top 10 | 3.42% | — | — |
| 三井住友信託銀行 last seen 2023 | Exited Top 10 | 1.14% | — | — |
| Concentration (HHI) ⓘ | 887 | 806 | 867 |
3 fiscal years · top-10 holders per year · >2,500 HHI = high concentration · entity-resolved
Portfolio Book Value
¥14,036M
-7% since 2023
Holdings
28
+2 new
4 exited
Trend
1 unwinding
vs 2023
| Held Company | FY2025 ¥14,036M total | FY2023 ¥15,141M total | |||
|---|---|---|---|---|---|
| Book Val ¥M | Shares | Book Val ¥M | Shares | ||
|
NOF CORPORATION
日油㈱
|
3,187 |
+200.0%
↑
1,578,000
|
3,245 | 526,000 | M |
|
ONO PHARMACEUTICAL CO., LTD.
小野薬品工業㈱
|
2,329 |
1,453,600
|
4,017 | 1,453,600 | M |
|
TOSOH CORPORATION
東ソー㈱
|
1,507 |
734,000
|
1,318 | 734,000 | M |
|
NIPPON KAYAKU CO.,LTD.
日本化薬㈱
|
843 |
597,600
|
715 | 597,600 | M |
|
OSAKA SODA CO.,LTD.
㈱大阪ソーダ
|
769 |
+400.0%
↑
474,000
|
412 | 94,800 | M |
|
KUMIAI CHEMICAL INDUSTRY CO., LTD.
クミアイ化学工業㈱
|
598 |
722,330
|
613 | 722,330 | M |
|
Nippon Soda Co., Ltd.
日本曹達㈱
|
580 |
+100.0%
↑
200,000
|
461 | 100,000 | M |
|
Sompo Holdings, Inc.
SOMPOホールディングス㈱
|
558 |
+200.0%
↑
123,600
|
216 | 41,200 | M |
|
SHIKOKU KASEI HOLDINGS CORPOLATION
四国化成ホールディングス㈱
|
492 |
268,000
|
376 | 268,000 | M |
|
Nisshin Oillio Group Co., Ltd.
日清オイリオグループ㈱
|
432 |
NEW
New
89,800
|
— | ||
|
TOKYO OHKA KOGYO CO., LTD.
東京応化工業㈱
|
419 |
+200.0%
↑
135,300
|
346 | 45,100 | M |
|
MITSUBISHI GAS CHEMICAL COMPANY,INC.
三菱瓦斯化学㈱
|
378 |
162,625
|
319 | 162,625 | M |
|
KAKEN PHARMACEUTIAL CO., LTD.
科研製薬㈱
|
375 |
83,800
|
309 | 83,800 | M |
|
KUREHA CORPORATION
㈱クレハ
|
316 |
+200.0%
↑
114,900
|
323 | 38,300 | M |
|
Hodogaya Chemical Co., Ltd.
保土谷化学工業㈱
|
312 |
+100.0%
↑
200,000
|
301 | 100,000 | M |
|
HOKKO CHEMICAL INDUSTRY CO.,LTD.
北興化学工業㈱
|
310 |
242,000
|
204 | 242,000 | M |
|
KANEKO SEEDS CO., LTD.
カネコ種苗㈱
|
188 |
134,310
|
223 | 134,310 | M |
|
Inabata & Co., Ltd.
稲畑産業㈱
|
129 |
-77.2%
↓
41,000
|
483 | 180,000 | M |
|
TOHO CHEMICAL INDUSTRY COMPANY,LIMITED
東邦化学工業㈱
|
101 |
150,000
|
73 | 150,000 | M |
|
Sumitomo Mitsui Trust Group, Inc.
三井住友トラストグループ㈱
|
83 |
NEW
New
22,460
|
— | M | |
|
SODA NIKKA CO., LTD.
ソーダニッカ㈱
|
51 |
50,000
|
40 | 50,000 | M |
|
SUGAI CHEMICAL INDUSTRY CO., LTD.
スガイ化学工業㈱
|
48 |
20,200
|
45 | 20,200 | M |
|
MITANI SANGYO CO.,LTD.
三谷産業㈱
|
21 |
66,000
|
21 | 66,000 | M |
|
Hokuriku Electric Power Company
北陸電力㈱
|
10 |
12,495
|
7 | 12,495 | |
|
Aica Kogyo Company, Limited
アイカ工業㈱
|
— | — | M | ||
|
ZERIA PHARMCEUTICAL CO., LTD.
ゼリア新薬工業㈱
|
— | — | |||
|
KH Neochem Co.,Ltd.
KHネオケム㈱
|
— | — | |||
|
YAKULT HONSHA CO.,LTD.
㈱ヤクルト本社
|
— | — | |||
| 日清オイリオ㈱ | — |
−100%
Exit
—
|
581 | 178,800 | M |
|
IINO KAIUN KAISHA, LTD.
飯野海運㈱
|
— |
−100%
Exit
—
|
372 | 371,200 | M |
| 三井住友トラストHD㈱ | — |
−100%
Exit
—
|
63 | 14,030 | M |
|
OSAKA ORGANIC CHEMICAL INDUSTRY LTD.
大阪有機化学工業㈱
|
— |
−100%
Exit
—
|
58 | 27,000 | M |
| Portfolio total | 14,036 | 15,141 | |||
Book value in ¥M · ↓ reduced · ↑ increased vs prior year · M = mutual holding